14th Operational Excellence in Clinical

14th Operational Excellence in Clinical Trials Summit (OECT Summit)

13th - 14th March 2024 | Berlin

You should not miss this annual opportunity if you are - Chiefs, Directors, Heads, Senior Manager, Leaders and Executives from:

REQUEST FULL AGENDA

Clinical Operations
Clinical Developments/Research
Clinical Trials/ Program/ Clinical Project/Operations
Study and Feasibility Management
Medical Operations/Monitoring Operations
International Clinical Research
Patient Recruitment & Retention
Medical Affairs/ Medical Advisors/ MSL
Data Management
Compliance and Regulatory
Patient Enrolment/ Patient Advocacy/ Patient Executive
Therapeutic Lead
Study Lead/ Study Delivery/ Study Director/PI
Clinical Site Management
Digital/Medical Technologies

For group discounts and complete details contact us.

WHO SHOULD ATTEND

CONFERENCE BENEFITS

Get engaged with the professionals from leading industries
20+ Keynote Sessions
5+ Workshop sessions
Round Table Discussions – Brain storming
Panel Discussions – Interact Directly with the Panellists to raise your challenges
More than 10 Case Studies presenting by the top experts from across the industry
13+ hours Networking Opportunity
Benchmarking Opportunities
One-to-one interactions
Tea/Coffee Breaks, Social Events and Cocktail Reception
.…and much more!

REQUEST FULL AGENDA

Opportunity to meet top expert and decision makers from Pharma, Biotech, Medical Devices, Clinical Sites and CROs industry under one Roof

OVERVIEW

BETTER STUDY PLANNING, BETTER DATA, BETTER PATIENTS, BETTER RESULTS.

A rewarding opportunity to join OECT Summit in three key locations in Berlin Germany, Toronto Canada and Philadelphia USA.

OECT Summit is targeted for professionals who are always seeking for new opportunities, visionary ways of conducting performance. Study Feasibility and Patient recruitment & retention offer major challenges to the clinical researcher, clinical project managers, clinical operation managers with potential for significant impact on timelines, budgets, CRA talent rejuvenation, collaborations & partnerships and ultimately the scientific integrity of the trial itself.

Many factors affect the recruitment of patients and difficulty in finding suitable patients is driving the development of many innovative methods for accessing new patient groups. How ‘Big Data Analytics and Date Driven Decision Making’ can have a significant impact in clinical trials. The artificial intelligence, remote trials/ virtual trials, decentralised trials, connected health and digitalisation means that new technologies and changing strategies for communication can be used to engage patients at early development stage, have feasibility right at first, accelerate site selection initiation process & great effect to reach out to patients directly.

Additionally, outreach through patient advocacy groups, social service agencies are becoming more important to communicate with patients viable for trial participation as well as for those already enrolled in clinical trials. How to maximise the benefit of this approach and ensure our regulatory obligations are appropriately met will be the subject of several sessions during the summit.

Don’t forget to check our OECT Summit editions in Canada and USA.

INTERESTED IN EVENT PARTNERSHIP?

KP Morgan specializes in clinical trials, SFE, commercial excellence and Healthcare innovation events, hosting events in various locations such as Canada, USA, Europe and Dubai.

KP-Morgan Conferences have provided platforms for debate across many industry sectors including: Telecommunication, banking & financial services, retail and FMCG, investments, pharmaceuticals, IT, chemical & petro chemical.

Many argue that the innovation process cannot be managed because innovation is supposed to be about creativity and cannot be predicted. We believe in KP-Morgan that Innovation is not only about being creative and inventive; innovation is a collaborative process where ideas are taken and managed through to value-adding market introduction.

The consistent high quality of our events has given rise to a reputation for excellence, ensuring that KP-Morgan conferences provide the most fertile ground for participants to gain up-to-the-minute market intelligence and invaluable opportunities to network and generate new business.

About KP-Morgan Group

AGENDA: TOPICS AT GLANCE

Keynote Presentation, Interactive Discussions, Case Studies, Brain Storming and Round Table Discussions

Study Feasibility, Study Site Operations, DHT's, DCTs and Patient Engagement

Engaging Sites and investigators: Optimizing Study Design
How to improve site relationship: Optimize CT operations and boost performance
Site Selection, Activation & Performance: Best Practices
Engaging Sites and Patients: study design,Site Selection Methodology
Complex of SOPs & eConsent
Changing Roles of Clinical Project Managers
Communication barriers in CROs, Sponsors & Sites: Key to successful partnership
Let's Make it work: Time, Quality, Budget & Rare Disease!
Rethinking the path to enrolment: Planning and Recruitment
Selecting Patient-Facing Technology: Why it is important for patient centric trials?
Patient Engagement and Retention Straregies
Diversity & Inclusion
Demonstrating Patient Insights at early drug development
Understanding technology advancement at patient level
Transforming Data and Data Driven Patient Recruitment
Holistic approach to patient recruitment ,Case Study: CNS, Rare Diseases Trials

Role of Technologies(ePRO, eTMF, EDC, CTMS) Digital Transformation(AI, DCTs) and Clinical Innovation
How DHTs(Digital Health Technology) advancing the clinical trials: Wearables, AI, Big Data Analytics, Telemedicine, Biomarkers, mobile apps
Intersecting Digital Health(wearables, mobile apps, Virtual Platforms) and Decentralized Clinical Trial Operations for Optimal Patient Outcomes
Solution to unmet clinical trial needs: Investigators perspective
Evolution of data science in data management
Data driven decision making
Leveraging RWD for Clinical Research
GCP challenges of using Connected Health solutions in clinical trials
Role of Sites, Site Engagement & Management
Central Vs Remote monitoring
From NCR to iPADs: CRA of the Future- Digital enabler
Cross functional KPIs
How data & Technology are changing the CPM role in Clinical Trials
Study Feasibility-Right at First
Study Oversight & Vendor Management Setup
Feasibility and protocol optimisation
Design Tools to effectively plan, manage and track your clinical study portfolio
Study Start-up & Resource Management
Study delivery: On-time and effectively
Trial Design, Regulatory aspects and Operations: Medical Device Perspectives

PATIENT EMPOWERMENT: AS PARTER

Diversity & Inclusion
How to retain patients in long run trials
Engaging Patients in Recruitment Strategies in Clinical Trial
Patient awareness program
Holistic approach to patient recruitment
Patient journey mapping
Case Study: Oncology Trials, Rare Diseases Trials, Diabetes Trials

Patient Centric Approaches
What role sites can play in patient recruitment
Role of Tech: What is means to patient?
Demonstrating Patient Insight from an early stage of drug development
Advancing use of patient centric platform trials
Patient Recruitment in Emerging countries and Challenges for Global Trials
Data driven patient recruitment

CLINICAL TECHNOLOGIES & TRENDS

eClinical Outcome Assessments/ePRO
(electronic Patient-Reported Outcome) Methods
A hybrid model for enablement of decentralized clinical trials and remote centralized monitoring (eSource)